Abstract:In our study, a novel hepatocyte-targeting norcantharidin (NCTD) derivative lactosyl-norcantharidin (Lac-NCTD) was synthesised using ethanediamine as a truss arm, and lactosyl-norcantharidin nanoparticles (Lac-NCTD-NPs) were obtained by an ionic cross-linkage process with an entrapment efficiency of (80.29 +/- 0.56)%. The release of Lac-NCTD-NPs invitro was then investigated by means of a dialysis method, and its sustained effect was evident. The invitro anti-tumour activities of Lac-NCTD and Lac-NCTD-NPs were studied by their cytotoxic effects on HepG2, SMMC-7721 and SGC-7901 cells. The results showed that the IC50 values of Lac-NCTD and Lac-NCTD-NPs cytotoxicity against HepG2 and SMMC-7721 cells were lower compared to NCTD, and the anti-tumour effects could be remarkably inhibited by galactosylated fetal bovine serum (Gal-FBS) as a competitor of the asialoglycoprotein receptor. The cytotoxic effects against SGC-7901 cells were relatively high, even higher than NCTD, and Gal-FBS had no influence on them at all. The amount of Lac-NCTD accumulated in SMMC-7721 cells was assayed by high-performance liquid chromatography, which indicated that Lac-NCTD may be able to permeate the cell membrane in its unchanged form. The anti-tumour activities of Lac-NCTD and Lac-NCTD-NPs invivo were evaluated in mice bearing an H22 tumour. The results suggested that tumour growth was effectively inhibited by all treatments, including NCTD, Lac-NCTD and Lac-NCTD-NPs, with Lac-NCTD-NPs being the most effective, followed by Lac-NCTD. As a result, Lac-NCTD-NPs may be regarded as liver-targeting agents, which combine both active and passive targeting.

An Investigation on Liver-Targeting Microemulsions of Norcantharidin.

[Studies on the Liver Targeting of Norcantharindin Microemulsion].

Study on the Distribution and Liver Targeting of Norcantharidin Nanoparticles in Mice

Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity

Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin

Formulation and characterization of albumin microspheres containing norcantharidate for liver tumor targeting.

Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin

Formulation and Physicochemical Characterization of Norcantharidin Microemulsion Containing Lecithin-Based Surfactants

Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate.

Preparation of a Novel Liver-Targeting Nanoparticle of Norcantharidin Derivative and Evaluation of Its Anti-Tumour Activity

Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity

Novel Norcantharidin-Loaded Liver Targeting Chitosan Nanoparticles to Enhance Intestinal Absorption

Nanoemulsion based lipid nanoparticles for effective demethylcantharidin delivery to cure liver cancer

Synthesis of Hepatocyte-Targeting Norcantharidin Prodrug and Preparation of Its Nanoparticles

Studies on Anti-Hepatocarcinoma Effect, Pharmacokinetics and Tissue Distribution of Carboxymethyl Chitosan Based Norcantharidin Conjugates.

Preparation and in Vitro Drug Release of Norcantharidin Sustained-release Microsphere for Hepatic Arterial Embolism

Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma

Studies on Preparation and Drug Release Characteristics of Norcantharidin Liposomes in Vitro

Development, Optimization and in Vitro Evaluation of Norcantharidin Loaded Self-Nanoemulsifying Drug Delivery Systems (Nctd-Snedds)

Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study

Liquid chromatography–tandem mass spectrometry evaluation of the pharmacokinetics of a diacid metabolite of norcantharidin loaded in folic acid-targeted liposomes in mice